Marshall Wace »

Entrada Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2024-03-31 $733k 52k 14.17
2023-06-30 $171k 11k 15.14
2023-03-31 $251k 17k 14.50

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Alphabet Inc-a Common Stock (GOOGL)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Vanguard S&p 500 Etp (VOO)
Alphabet Inc-c Common Stock (GOOG)
Spdr S&p 500 Etf Equity Option Put Option (SPY)
Danaher Corp Common Stock (DHR)
Meta Platforms-a Common Stock (META)
Netflix Common Stock (NFLX)
Costco Wholesale Common Stock (COST)
Procter & Gamble Common Stock (PG)
Adv Micro Device Common Stock (AMD)

View all positions for Marshall Wace

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
MPM Asset Management
5AM Venture Management
T. Rowe Price Associates
BlackRock
Redmile Group
Vanguard Group
Wellington Management Company
StepStone
TCG Crossover Management
Geode Capital Management
State Street Corporation
American Century Companies
Northern Trust
FMR

View all funds holding Entrada Therapeutics